Comprehensive Analytics and Characterization of Glycan Pairing in Fc-containing Biotherapeutics

Characterization of Antibody Variants in Process Development

LC-MS Methodologies to Assess 5’ Cap and 3’Poly A Tail Quality Attributes

Introducing the BioAccord LC-MS System, Where Power Meets Simplicity

The Power of Partnership with Bayer – Advancing the Future of Innovative LNP Formulation Development

The Power of Partnership with Boehringer Ingelheim – Advancing the Future of Protein Therapeutics Characterization

The Power of Partnership with Pfizer – Advancing the Future of Upstream Process Development

The Power of Partnership with Cytiva – Advancing the Future of Traditional and Complex Antibody Characterization

Oligonucleotide Sequence Confirmation for Quality Control by Micheal Ruhl from BioSpring

ASMS 2024 Recap Featuring the BioAccord LC-MS System for Accelerated Biopharmaceutical Analysis

バイオプロセスおよび開発におけるバイオシミラーモノクローナル抗体（mAb）候補のマルチ特性モニタリングのための合理化された mAb サブユニット LC-MS ワークフロー

製品品質の向上 - BioAccord

The BioAccord LC-MS System & Ambr 250 Data Interface | Increase Efficiency with Two-way Data Sharing

Direct LC-MS Measurement in Upstream Bioprocess – Make Better and More Informed Decisions Faster

DEMO | The waters_connect Software Data Interface for Sartorius Ambr System